Cannabigerol for Bladder Cancer Recovery

This trial tests cannabigerol, a compound in cannabis, to determine its effectiveness in aiding recovery from bladder cancer surgery. The study seeks to discover if cannabigerol gummies can safely alleviate symptoms and enhance the quality of life for individuals undergoing radical cystectomy with urinary diversion. California residents with non-metastatic bladder cancer, scheduled for this specific surgery and able to refrain from using other cannabis products during the study, are eligible to participate. As an Early Phase 1 trial, this research focuses on understanding how cannabigerol functions in people, offering participants the chance to be among the first to receive this innovative treatment.

The trial information does not specify if you need to stop taking your current medications. However, you must refrain from using any non-study cannabis during the study.

Research has shown that cannabigerol (CBG), a compound in cannabis, is generally safe and well-tolerated. In one study with healthy participants, 44% experienced no side effects, and those who did reported only mild ones. This indicates that side effects are usually not serious and can be managed.

Unlike the standard treatments for bladder cancer, which often involve surgery, chemotherapy, and radiation therapy, cannabigerol (CBG) offers a unique approach. CBG is a compound derived from cannabis that may have anti-inflammatory and anti-cancer properties, providing a new mechanism of action by targeting the body's cannabinoid receptors. This treatment is delivered as gummies, offering an easy and non-invasive way to administer the medication compared to traditional methods. Researchers are particularly excited about the potential of CBG to support recovery without the harsh side effects commonly associated with conventional therapies.

Research has shown that cannabigerol (CBG) might alleviate symptoms of bladder cancer. CBG blocks certain signals in the body that cause bladder pain and overactivity, potentially relieving pain. Early studies suggest that CBG could also help kill cancer cells, offering promise for treatment. Although more research is needed, these early results provide hope that CBG could improve recovery and quality of life after bladder cancer surgery. Participants in this trial will receive cannabigerol gummies to evaluate its effects during the perioperative period and up to 30 days postoperatively.¹²³⁶⁷